RDNT - ラドネット （RadNet Inc.） ラドネットRDNTのチャート
RDNTの企業情報
| symbol | RDNT |
|---|---|
| 会社名 | RadNet Inc （ラドネット） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical Specialities |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | 事業概要 ラドネット(RadNet Inc)は米国で自立、固定サイトの外来患者向け画像診断サービスの提供に従事する。同社のセンターは医師に病気・疾患の診断と治療を容易にするイメージング機能を提供する。同社のサービスは磁気共鳴画像(MRI)、コンピュータ断層撮影(CT)、陽電子放出断層撮影(PET)、核医学、マンモグラフィ、超音波、診断放射線医学(X線)、透視診断法及びその他治療サービスを提供する。 ラドネットは米国の画像診断サ―ビス企業。カリフォルニア、メリ―ランド、フロリダ、デラウェア、ニュ―ジャ―ジ―、ロ―ドアイランド、ニューヨークの各州で外来患者用画像診断センタ―を運営。磁気共鳴イメ―ジング、コンピュ―タ断層撮影、陽電子断層撮影、核医学、マンモグラフィ―、超音波診断放射線(X線)、X線透視及び関連サ―ビスを提供。 RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 334 owned and/or operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware, New Jersey, New York and Arizona. In addition, RadNet provides radiology information technology solutions, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 8,600 employees. |
| 本社所在地 | 1510 Cotner Avenue Los Angeles CA 90025 USA |
| 代表者氏名 | Howard G. Berger ハワード・G・バーガー |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 310-478-7808 |
| 設立年月日 | 31321 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 7525人 |
| url | www.radnet.com |
| nasdaq_url | https://www.nasdaq.com/symbol/rdnt |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 114.94500 |
| 終値（lastsale） | 15.74 |
| 時価総額（marketcap） | 760004735.24 |
| 時価総額 | 時価総額（百万ドル） 738.27660 |
| 売上高 | 売上高（百万ドル） 938.94600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1316.9176 |
| 当期純利益 | 当期純利益（百万ドル） 7.52100 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 RadNet Inc. revenues increased 4% to $475.8M. Net loss totaled $1.9M vs. income of $4.1M. Revenues reflect Provision for bad debts decrease from $23.5M to $0K. Net loss reflects Building and equipment rental increase of 11% to $43.2M (expense) Depreciation and amortization increase of 8% to $35.9M (expense) Gain on sale of imaging centers decrease from $2.3M (income) to $0K. |
RDNTのテクニカル分析
RDNTのニュース
Global Mammography Market Analysis Report 2022: Transformational Growth Driven by Disruptive AI Solutions Enhancing Workflow Efficiency and Clinical Decision-Making 2022/08/29 20:00:00 Kwhen Finance
RadNet Stock: Risk Premia To Deliver Risk-Adjusted Alpha (NASDAQ:RDNT) 2022/08/28 12:00:00 Seeking Alpha
RadNet came in with another strong quarter in Q2 FY22 with operating metrics in-line with longer-term trends. Read why we rate RDNT stock a Buy.
RadNet, Inc. (RDNT) CEO Howard Berger on Q2 2022 Results - Earnings Call Transcript 2022/08/13 10:01:09 Seeking Alpha
RadNet, Inc. (NASDAQ:NASDAQ:RDNT) Q2 2022 Earnings Conference Call August 09, 2022, 10:30 AM ET Company Participants Mark Stolper - EVP and CFO Howard Berger - CEO Conference Call…
RADNET, INC. – 10-Q – Management''s Discussion and Analysis of Financial Condition and Results of Operations 2022/08/09 20:49:09 InsuranceNewsNet
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10- Q and with our audited consolidated financial statements and notes thereto for the year…
RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance 2022/08/09 10:10:34 Seeking Alpha
RadNet press release (NASDAQ:RDNT): Q2 Non-GAAP EPS of $0.15 beats by $0.06.Revenue of $354.1M (+6.0% Y/Y) beats by $5.16M.For FY2022, the company reaffirms revenue between $1.36B to…
Global Mammography Market Analysis Report 2022: Transformational Growth Driven by Disruptive AI Solutions Enhancing Workflow Efficiency and Clinical Decision-Making 2022/08/29 20:00:00 Kwhen Finance
RadNet Stock: Risk Premia To Deliver Risk-Adjusted Alpha (NASDAQ:RDNT) 2022/08/28 12:00:00 Seeking Alpha
RadNet came in with another strong quarter in Q2 FY22 with operating metrics in-line with longer-term trends. Read why we rate RDNT stock a Buy.
RadNet, Inc. (RDNT) CEO Howard Berger on Q2 2022 Results - Earnings Call Transcript 2022/08/13 10:01:09 Seeking Alpha
RadNet, Inc. (NASDAQ:NASDAQ:RDNT) Q2 2022 Earnings Conference Call August 09, 2022, 10:30 AM ET Company Participants Mark Stolper - EVP and CFO Howard Berger - CEO Conference Call…
RADNET, INC. – 10-Q – Management''s Discussion and Analysis of Financial Condition and Results of Operations 2022/08/09 20:49:09 InsuranceNewsNet
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10- Q and with our audited consolidated financial statements and notes thereto for the year…
RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance 2022/08/09 10:10:34 Seeking Alpha
RadNet press release (NASDAQ:RDNT): Q2 Non-GAAP EPS of $0.15 beats by $0.06.Revenue of $354.1M (+6.0% Y/Y) beats by $5.16M.For FY2022, the company reaffirms revenue between $1.36B to…
RadNet, Inc. Announces Date of its Second Quarter 2022 Financial Results Conference Call 2022/07/25 10:00:00 GlobeNewswire
LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its second quarter 2022 financial results on Tuesday, August 9 th , 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
RadNet AI-based software solutions for breast, prostate cancers gets FDA clearance 2022/05/16 12:26:24 Seeking Alpha
RadNet (RDNT) said it received U.S. FDA clearances for its DeepHeatlh Saige-DX mammography and Quantib Prostate 2.0 MRI artificial intelligence ((AI)) algorithms
RADNET, INC. – 10-Q – Management''s Discussion and Analysis of Financial Condition and Results of Operations 2022/05/10 22:04:21 InsuranceNewsNet
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10- Q and with our audited consolidated financial statements and notes thereto for the year… The post RADNET, INC. – 10-Q – Management''s Discussion and Analysis of Financial Condition and Results of Operations appeared first on InsuranceNewsNet .
RadNet Slips 4% as Investors Frown on Mixed Q1 Performance 2022/05/10 12:48:27 TipRanks
Radiology company RadNet, Inc. (NASDAQ: RDNT) recently reported mixed results for the first quarter ended March 31, 2022. Following the results, shares of the company declined 4.4% to close at $18.16 in Monday’s extended trading session. Revenue & Earnings Revenues for the quarter stood at $341.8 million, up 8.4% year-over-year. Further, the figure surpassed the consensus estimate of $330.41 million. Service fee revenue grew 8.5% year-over-year to $303.3 million and contributed to the overall growth in revenues. The company reported a loss of $0.15 per share against the consensus estimate of $0. RadNet had posted earnings of $0.05 per share in the same quarter last year.
RadNet, Inc. (RDNT) CEO Howard Berger on Q1 2022 Results - Earnings Call Transcript 2022/05/09 18:26:03 Seeking Alpha
RadNet, Inc. (NASDAQ:NASDAQ:RDNT) Q1 2022 Earnings Conference Call May 9, 2022 10:30 ET Company Participants Mark Stolper - Executive Vice President and Chief Financial Officer Howard…